Pargyline
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Pargyline is a monoamine oxidase B (MAO-B) inhibitor. It functions by inhibiting the metabolism of catecholamines and tyramine within presynaptic nerve terminals. Patients taking pargyline must avoid concurrent consumption of tyramine-containing foods such as bleu cheese and beer, as this can lead to a hypertensive crisis.[1]
References
- ↑ Tulane University School of Medicine Department of Pharmacology: Autonomic Drug Profile handout, October 2006
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH